Carlyle Group Amends QuidelOrtho Stake Filing
Ticker: CGABL · Form: SC 13D/A · Filed: Jul 24, 2024 · CIK: 1527166
| Field | Detail |
|---|---|
| Company | Carlyle Group Inc. (CGABL) |
| Form Type | SC 13D/A |
| Filed Date | Jul 24, 2024 |
| Risk Level | medium |
| Pages | 9 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.001, $31.36, $31.99, $31.7063, $32.02 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
Related Tickers: QDEL
TL;DR
Carlyle Group updated its 13D filing for QuidelOrtho (QDEL) - ownership details changed.
AI Summary
Carlyle Group Inc. filed an amendment to its Schedule 13D on July 24, 2024, related to its beneficial ownership of QuidelOrtho Corp. The filing indicates a change in the reporting person's holdings, though specific new dollar amounts or percentages are not detailed in this excerpt. The amendment pertains to QuidelOrtho Corp, a company in the in vitro and in vivo diagnostic substances industry.
Why It Matters
This filing signals a potential shift in the ownership structure or strategy of QuidelOrtho Corp, which could impact its stock performance and future business decisions.
Risk Assessment
Risk Level: medium — Changes in major shareholder filings can indicate shifts in strategy or potential future actions that may affect the company's stock.
Key Players & Entities
- Carlyle Group Inc. (company) — Filing entity
- QuidelOrtho Corp (company) — Subject company
- 20240724 (date) — Filing date
FAQ
What specific changes in beneficial ownership are reported by Carlyle Group Inc. in this SC 13D/A filing?
The filing is an amendment to a previous Schedule 13D, indicating a change in reporting person's holdings, but the specific details of the change (e.g., number of shares, percentage ownership) are not provided in this excerpt.
When was this SC 13D/A filing submitted?
The filing was submitted on July 24, 2024.
What is the primary business of QuidelOrtho Corp?
QuidelOrtho Corp is in the In Vitro & In Vivo Diagnostic Substances industry.
What is the business address of Carlyle Group Inc. as listed in the filing?
The business address for Carlyle Group Inc. is C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON, DC 20004.
What was QuidelOrtho Corp's former company name?
QuidelOrtho Corp's former company name was Coronado Topco, Inc.
Filing Stats: 2,596 words · 10 min read · ~9 pages · Grade level 6.9 · Accepted 2024-07-24 16:30:06
Key Financial Figures
- $0.001 — relating to the common stock, par value $0.001 per share (the “Common Stock&rdqu
- $31.36 — ice Per Share July 12, 2024 4,722 $31.36 to $31.99 $31.7063 July 12, 2024
- $31.99 — are July 12, 2024 4,722 $31.36 to $31.99 $31.7063 July 12, 2024 52,531 $
- $31.7063 — y 12, 2024 4,722 $31.36 to $31.99 $31.7063 July 12, 2024 52,531 $32.02 to $3
- $32.02 — 9 $31.7063 July 12, 2024 52,531 $32.02 to $32.70 $32.4089 July 15, 2024
- $32.70 — 63 July 12, 2024 52,531 $32.02 to $32.70 $32.4089 July 15, 2024 90,507 $
- $32.4089 — 12, 2024 52,531 $32.02 to $32.70 $32.4089 July 15, 2024 90,507 $31.3251 to
- $31.3251 — 0 $32.4089 July 15, 2024 90,507 $31.3251 to $31.996 $31.6896 July 15, 2024
- $31.996 — July 15, 2024 90,507 $31.3251 to $31.996 $31.6896 July 15, 2024 2,680 $3
- $31.6896 — , 2024 90,507 $31.3251 to $31.996 $31.6896 July 15, 2024 2,680 $32.00 to $32
- $32.00 — 96 $31.6896 July 15, 2024 2,680 $32.00 to $32.2993 $32.1535 July 16, 2024
- $32.2993 — 896 July 15, 2024 2,680 $32.00 to $32.2993 $32.1535 July 16, 2024 6,736 $3
- $32.1535 — 15, 2024 2,680 $32.00 to $32.2993 $32.1535 July 16, 2024 6,736 $31.47 to $31
- $31.47 — 93 $32.1535 July 16, 2024 6,736 $31.47 to $31.9984 $31.7621 July 16, 2024
- $31.9984 — 535 July 16, 2024 6,736 $31.47 to $31.9984 $31.7621 July 16, 2024 25,995 $
Filing Documents
- formsc13da.htm (SC 13D/A) — 284KB
- 0001493152-24-028929.txt ( ) — 286KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : July 24, 2024 The Carlyle Group Inc. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II GP L.L.C. By: The Carlyle Group Inc., its sole member By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director CG Subsidiary Holdings L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings, L.P. By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings Sub L.P. By: TC Group Cayman Investment Holdings, L.P., its general partner By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group VI Cayman, L.L.C. By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President TC Group VI Cayman, L.P. By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President Carlyle Partners VI Cayman Holdings, L.P. By: TC Group VI Cayman, L.P., its general partner By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President